Item 9 Labs Corp.
INLB - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$10.18K
Close$
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $10,184.00 |
|---|---|
| Enterprise Value | $34.32 Million |
| Earnings per Share | $-0.33 |
| Beta | 0.14 |
| Outstanding Shares | 101,840,276 |
Return
| Return on Equity | -58.91% |
|---|---|
| Return on Assets | -27.69% |
| Return on Invested Capital | -40.71% |
Valuation & Multiples
| P/E Ratio | 0 |
|---|---|
| PEG | 0 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 1.74 |
| Enterprise Value to EBIT | -1.58 |
| Enterprise Value to Net Income | -2 |
| Total Debt to Enterprise | 1.01 |
| Debt to Equity | 0.66 |
Revenue Sources
No data
Last Earnings Call
Report Date
August 31, 2026
EPS Estimate
$-0.04
Consensus analyst estimateRevenue Estimate
$6.50 M
Consensus analyst estimateNext Earnings Call
Expected Date
December 2, 2026
EPS Estimate
$-0.04
Consensus analyst estimateRevenue Estimate
$6.50 M
Consensus analyst estimateInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About Item 9 Labs Corp.
97 employees
CEO: Jeffrey I. Rassas
Based in the United States, Item 9 Labs Corp. operates as a comprehensive cannabis company, encompassing both vertical integration in cannabis operations and the franchising of dispensaries. The firm produces a wide spectrum of cannabis ...